OCULAR THERAPEUTIX INC. - COMMON STOCK

Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting

03 фев 2025 07:00:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR

14 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation

08 янв 2025 07:00:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

13 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference

10 дек 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1

02 дек 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences

26 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights

14 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV

13 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer

12 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024

06 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK

28 окт 2024 10:00:04 Источник NetDania Notify

NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK

21 окт 2024 09:47:37 Источник NetDania Notify

NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK

16 окт 2024 15:33:40 Источник NetDania Notify

Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD

15 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

09 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at October Ophthalmology Meetings

09 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024

25 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

12 сен 2024 16:05:00 Источник Nasdaq GlobeNewswire